Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Isis Pharmaceuticals: Another Regeneron (Or Even Better) In The Making?
Seeking Alpha
Sun, 06/14/15 - 10:48 pm
Tags:
Isis Pharmaceuticals, Regeneron, antisense
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
Tags:
biotech, GSK, Axovant Sciences, Alzheimer's disease, PCSK9 inhibitors, Praluent, Sanofi, Regeneron, Repatha, Amgen
Why Is Amgen Rising And Regeneron Falling?
Barron's
Fri, 06/12/15 - 10:44 am
Tags:
Amgen, Regeneron, Sanofi, Repatha, Praluent, FDA, advisory panels, PCSK9 inhibitors
Why Regeneron’s down on a positive FDA recommendation
CNBC
Wed, 06/10/15 - 02:36 pm
Tags:
Regeneron, Sanofi, Praluent, FDA, advisory panels, PCSK9 inhibitors
How The New Cholesterol Drugs From Amgen And Regeneron Could Still Be Blockbusters
Forbes
Wed, 06/10/15 - 09:08 am
Tags:
Amgen, Regeneron, PCSK9 inhibitors, Repatha, Praluent
Sanofi/Regeneron's PCSK9 blockbuster-in-waiting gets prelim FDA nod
BioPharma Dive
Tue, 06/9/15 - 06:33 pm
Tags:
Sanofi, Regeneron, PCSK9 inhibitors, FDA, advisory panels, Praluent
PCSK9 adcomm preview: what's at stake
Medical Marketing and Media
Tue, 06/9/15 - 09:32 am
Tags:
PCSK9 inhibitors, FDA, advisory panels, Sanofi, Regeneron, Amgen, Repatha, Praluent
New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels
24/7 Wall St
Sun, 06/7/15 - 10:57 am
Tags:
FDA, advisory panels, Regeneron, AbbVie, Amgen, Repatha, alirocumab, PCSK9 inhibitors
The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week
Barron's
Fri, 06/5/15 - 12:22 pm
Tags:
FDA, advisory panels, Regeneron, Sanofi, Amgen, PCSK9 inhibitors, Praluent
FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
Yahoo/Reuters
Fri, 06/5/15 - 09:20 am
Tags:
FDA, Sanofi, Regeneron, alirocumab, advisory panels
For The Pricing Of New Cholesterol Lowering PCSK-9 Drugs, Does Dose Size Matter?
Forbes
Mon, 06/1/15 - 12:16 pm
Tags:
PCSK9 inhibitors, drug pricing, Amgen, Sanofi, Regeneron, Pfizer
5 Drugs That Could Be Summer Blockbusters
Investors.com
Wed, 05/27/15 - 11:06 am
Tags:
Valeant Pharmaceuticals, Actavis, Xifaxan, Orkambi, Vertex Pharmaceuticals, Regeneron, Sanofi, Amgen, Repatha, eluxadoline, Praluent
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Tags:
Gilead Sciences, PCSK9 inhibitors, Amgen, Sanofi, Regeneron, drug pricing, Repatha, Praluent
Fight over hot new cholesterol drugs may be won in milligrams
Yahoo/Reuters
Tue, 05/26/15 - 09:37 am
Tags:
Amgen, Repatha, Regeneron, Sanofi, Praluent
The Most Loved Biotechs of Big Hedge Funds
24/7 Wall St
Sat, 05/23/15 - 11:41 am
Tags:
biotech, Pharmacyclics, Gilead Sciences, Regeneron, Celgene, Amgen
A Beautiful Biotech Summer?
Barron's
Fri, 05/22/15 - 06:39 pm
Tags:
biotech, Biogen, Alexion, Amgen, Celgene, Regeneron
Regeneron's arthritis drug nails it in phase III
BioPharma Dive
Fri, 05/22/15 - 10:44 am
Tags:
Regeneron, Sarilumab, rheumatoid arthritis
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
BioPharma Dive
Thu, 05/21/15 - 08:47 am
Tags:
Amgen, PCSK9 inhibitor, Repatha, Europe, Sanofi, Regeneron, Praluent
Sanofi/Regeneron reports glowing phase 2b results for versatile asthma hopeful
BioPharma Dive
Wed, 05/20/15 - 06:18 pm
Tags:
Sanofi, Regeneron, dupilumab, asthma
Regeneron speeds toward the FDA with its would-be asthma blockbuster
Fierce Biotech
Mon, 05/18/15 - 09:56 pm
Tags:
Regeneron, FDA, asthma, dupilumab, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.